Shree Ganesh Remedies Limited
Shree Ganesh Remedies Limited Fundamental Analysis
Shree Ganesh Remedies Limited (SGRL.BO) shows weak financial fundamentals with a PE ratio of 36.78, profit margin of 17.99%, and ROE of 12.54%. The company generates $1.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 67.0/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze SGRL.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakSGRL.BO struggles to generate sufficient returns from assets.
Valuation Score
ModerateSGRL.BO shows balanced valuation metrics.
Growth Score
ModerateSGRL.BO shows steady but slowing expansion.
Financial Health Score
ExcellentSGRL.BO maintains a strong and stable balance sheet.
Profitability Score
WeakSGRL.BO struggles to sustain strong margins.
Key Financial Metrics
Is SGRL.BO Expensive or Cheap?
P/E Ratio
SGRL.BO trades at 36.78 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, SGRL.BO's PEG of -3.23 indicates potential undervaluation.
Price to Book
The market values Shree Ganesh Remedies Limited at 4.33 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 18.10 times EBITDA. This signals the market has high growth expectations.
How Well Does SGRL.BO Make Money?
Net Profit Margin
For every $100 in sales, Shree Ganesh Remedies Limited keeps $17.99 as profit after all expenses.
Operating Margin
Core operations generate 31.70 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $12.54 in profit for every $100 of shareholder equity.
ROA
Shree Ganesh Remedies Limited generates $8.86 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Shree Ganesh Remedies Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Shree Ganesh Remedies Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
SGRL.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
36.78
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-3.23
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.33
vs 25 benchmark
P/S Ratio
Price to sales ratio
6.62
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.24
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.001
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.13
vs 25 benchmark
ROA
Return on assets percentage
0.09
vs 25 benchmark
ROCE
Return on capital employed
0.17
vs 25 benchmark
How SGRL.BO Stacks Against Its Sector Peers
| Metric | SGRL.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 36.78 | 29.45 | Worse (Expensive) |
| ROE | 12.54% | 779.00% | Weak |
| Net Margin | 17.99% | -24936.00% (disorted) | Strong |
| Debt/Equity | 0.24 | 0.26 | Neutral |
| Current Ratio | 4.00 | 4.65 | Strong Liquidity |
| ROA | 8.86% | -19344.00% (disorted) | Weak |
SGRL.BO outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Shree Ganesh Remedies Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation